Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Cramer

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Danish Medical Journal|March 4, 2021
Validity of sports-related diagnosis codes in the Danish National Patient RegisterMarkus Normann Gadeberg, Allan Cramer, Per Hölmic, et al.
Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons|November 27, 2021
Neither heel-rise Height (HRH) nor Achilles tendon resting angle (ATRA) show strong correlations to patient limitations and return to previous activities one year after acute Achilles tendon ruptureAllan Cramer, Maria Swennergren Hansen, Per Hölmich, et al.
Orthopaedic Journal of Sports Medicine|August 19, 2022
Involvement of Bacteria in the Pathological Changes Before Achilles Tendon Rupture: A Case Series Investigating 16S rDNA in 20 Consecutive RupturesAllan Cramer, Claus Moser, Blaine Gabriel Fritz, et al.
Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons|March 1, 2022
Genetic contribution to the etiology of Achilles tendon rupture. A Danish nationwide register study of twinsAllan Cramer, Kristoffer Weisskirchner Barfod, Per Hölmich, et al.
Ugeskrift for Laeger|March 27, 2024
Iben Rix, Ida Marie Heerfordt, Allan Cramer, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|November 15, 2021
Estimation of Patient Acceptable Symptom State (PASS) and Treatment Failure (TF) Threshold Values for the Achilles Tendon Total Rupture Score (ATRS) at 6 Months, 1 Year, and 2 Years After Acute Achilles Tendon RuptureAllan Cramer, Lina Holm Ingelsrud, Maria Swennergren Hansen, et al.
British Journal of Clinical Pharmacology|May 1, 2026
Advanced therapy medicinal products (ATMPs) - An analysis of the global regulatory statusAllan Cramer, Freja Karuna Hemmingsen Sørup, Marie Lund, et al.
JAMA Oncology|November 14, 2024
Regulatory Fate of Cancer Indications in the European Union After Accelerated Approval in the USTonny Studsgaard Petersen, Kristian Karstoft, Freja Karuna Hemmingsen Sørup, et al.
Journal of Cancer Policy|November 7, 2025
Discrepancies in the therapeutic indications granted by the European Medicines Agency and the US Food and Drug Administration for new cancer drugs: An analysis of potential explanationsAllan Cramer, Freja Karuna Hemmingsen Sørup, Hanne Rolighed Christensen, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|January 2, 2021
No clinically relevant difference between operative and non-operative treatment in tendon elongation measured with the Achilles tendon resting angle (ATRA) 1 year after acute Achilles tendon ruptureAllan Cramer, Ebrahim Rahdi, Maria Swennergren Hansen, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Danish Medical Journal|March 4, 2021
Validity of sports-related diagnosis codes in the Danish National Patient RegisterMarkus Normann Gadeberg, Allan Cramer, Per Hölmic, et al.
Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons|November 27, 2021
Neither heel-rise Height (HRH) nor Achilles tendon resting angle (ATRA) show strong correlations to patient limitations and return to previous activities one year after acute Achilles tendon ruptureAllan Cramer, Maria Swennergren Hansen, Per Hölmich, et al.
Orthopaedic Journal of Sports Medicine|August 19, 2022
Involvement of Bacteria in the Pathological Changes Before Achilles Tendon Rupture: A Case Series Investigating 16S rDNA in 20 Consecutive RupturesAllan Cramer, Claus Moser, Blaine Gabriel Fritz, et al.
Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons|March 1, 2022
Genetic contribution to the etiology of Achilles tendon rupture. A Danish nationwide register study of twinsAllan Cramer, Kristoffer Weisskirchner Barfod, Per Hölmich, et al.
Ugeskrift for Laeger|March 27, 2024
Iben Rix, Ida Marie Heerfordt, Allan Cramer, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|November 15, 2021
Estimation of Patient Acceptable Symptom State (PASS) and Treatment Failure (TF) Threshold Values for the Achilles Tendon Total Rupture Score (ATRS) at 6 Months, 1 Year, and 2 Years After Acute Achilles Tendon RuptureAllan Cramer, Lina Holm Ingelsrud, Maria Swennergren Hansen, et al.
British Journal of Clinical Pharmacology|May 1, 2026
Advanced therapy medicinal products (ATMPs) - An analysis of the global regulatory statusAllan Cramer, Freja Karuna Hemmingsen Sørup, Marie Lund, et al.
JAMA Oncology|November 14, 2024
Regulatory Fate of Cancer Indications in the European Union After Accelerated Approval in the USTonny Studsgaard Petersen, Kristian Karstoft, Freja Karuna Hemmingsen Sørup, et al.
Journal of Cancer Policy|November 7, 2025
Discrepancies in the therapeutic indications granted by the European Medicines Agency and the US Food and Drug Administration for new cancer drugs: An analysis of potential explanationsAllan Cramer, Freja Karuna Hemmingsen Sørup, Hanne Rolighed Christensen, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|January 2, 2021
No clinically relevant difference between operative and non-operative treatment in tendon elongation measured with the Achilles tendon resting angle (ATRA) 1 year after acute Achilles tendon ruptureAllan Cramer, Ebrahim Rahdi, Maria Swennergren Hansen, et al.
Pageof 2